Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allogeneic Granulocyte Donation: later-stage trial registry
1 of 1 indexed Allogeneic Granulocyte Donation trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Allogeneic Granulocyte Donation: 1 US clinical trial tracked, 1 recruiting.
Allogeneic Granulocyte Donation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is National Institutes of Health Clinical Center (CC), running 1 of these trials.
Enrollment posture brief
Registry condition allogeneic-granulocyte-donation
OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Allogeneic Granulocyte Donation lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Allogeneic Granulocyte Donation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Allogeneic Granulocyte Donation is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Allogeneic Granulocyte Donation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Allogeneic Granulocyte Donation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Allogeneic Granulocyte Donation page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Allogeneic Granulocyte Donation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institutes of Health Clinical Center (CC) sponsors the most Allogeneic Granulocyte Donation trials on record, review their full trial history before evaluating a specific study. See National Institutes of Health Clinical Center (CC)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allogeneic Granulocyte Donation condition card totals 1 registered trials; most-linked intervention Filgrastim; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.